vs

Side-by-side financial comparison of COUSINS PROPERTIES INC (CUZ) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

COUSINS PROPERTIES INC is the larger business by last-quarter revenue ($255.0M vs $197.9M, roughly 1.3× REPLIGEN CORP). REPLIGEN CORP runs the higher net margin — 6.7% vs -1.4%, a 8.1% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 13.2%). COUSINS PROPERTIES INC produced more free cash flow last quarter ($135.0M vs $17.6M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 10.4%).

Cousins Properties Incorporated is a publicly traded real estate investment trust (REIT) that invests in office buildings in Atlanta, Charlotte, Austin, Phoenix, Tampa, and Chapel Hill, North Carolina. The company has developed notable properties including CNN Center, Omni Coliseum, 191 Peachtree Tower, and Emory Point in Atlanta.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

CUZ vs RGEN — Head-to-Head

Bigger by revenue
CUZ
CUZ
1.3× larger
CUZ
$255.0M
$197.9M
RGEN
Growing faster (revenue YoY)
RGEN
RGEN
+0.5% gap
RGEN
13.6%
13.2%
CUZ
Higher net margin
RGEN
RGEN
8.1% more per $
RGEN
6.7%
-1.4%
CUZ
More free cash flow
CUZ
CUZ
$117.5M more FCF
CUZ
$135.0M
$17.6M
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
10.4%
CUZ

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CUZ
CUZ
RGEN
RGEN
Revenue
$255.0M
$197.9M
Net Profit
$-3.5M
$13.3M
Gross Margin
67.4%
52.5%
Operating Margin
67.5%
9.0%
Net Margin
-1.4%
6.7%
Revenue YoY
13.2%
13.6%
Net Profit YoY
-125.4%
143.9%
EPS (diluted)
$-0.02
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CUZ
CUZ
RGEN
RGEN
Q4 25
$255.0M
$197.9M
Q3 25
$248.3M
$188.8M
Q2 25
$240.1M
$182.4M
Q1 25
$250.3M
$169.2M
Q4 24
$225.3M
$174.1M
Q3 24
$209.2M
$154.9M
Q2 24
$213.0M
$154.1M
Q1 24
$209.2M
$151.3M
Net Profit
CUZ
CUZ
RGEN
RGEN
Q4 25
$-3.5M
$13.3M
Q3 25
$8.6M
$14.9M
Q2 25
$14.5M
$14.9M
Q1 25
$20.9M
$5.8M
Q4 24
$13.6M
$-30.3M
Q3 24
$11.2M
$-654.0K
Q2 24
$7.8M
$3.3M
Q1 24
$13.3M
$2.1M
Gross Margin
CUZ
CUZ
RGEN
RGEN
Q4 25
67.4%
52.5%
Q3 25
67.8%
53.2%
Q2 25
69.1%
50.0%
Q1 25
69.2%
53.6%
Q4 24
67.6%
26.1%
Q3 24
68.5%
50.0%
Q2 24
66.8%
49.8%
Q1 24
66.0%
49.5%
Operating Margin
CUZ
CUZ
RGEN
RGEN
Q4 25
67.5%
9.0%
Q3 25
68.1%
8.9%
Q2 25
69.4%
7.6%
Q1 25
66.0%
3.9%
Q4 24
65.8%
-17.7%
Q3 24
67.9%
-5.1%
Q2 24
66.4%
1.0%
Q1 24
66.3%
1.3%
Net Margin
CUZ
CUZ
RGEN
RGEN
Q4 25
-1.4%
6.7%
Q3 25
3.5%
7.9%
Q2 25
6.0%
8.2%
Q1 25
8.3%
3.4%
Q4 24
6.1%
-17.4%
Q3 24
5.4%
-0.4%
Q2 24
3.7%
2.2%
Q1 24
6.4%
1.4%
EPS (diluted)
CUZ
CUZ
RGEN
RGEN
Q4 25
$-0.02
$0.24
Q3 25
$0.05
$0.26
Q2 25
$0.09
$0.26
Q1 25
$0.12
$0.10
Q4 24
$0.09
$-0.55
Q3 24
$0.07
$-0.01
Q2 24
$0.05
$0.06
Q1 24
$0.09
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CUZ
CUZ
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$5.7M
$767.6M
Total DebtLower is stronger
$3.3B
$542.2M
Stockholders' EquityBook value
$4.7B
$2.1B
Total Assets
$8.9B
$2.9B
Debt / EquityLower = less leverage
0.71×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CUZ
CUZ
RGEN
RGEN
Q4 25
$5.7M
$767.6M
Q3 25
$4.7M
$748.7M
Q2 25
$416.8M
$708.9M
Q1 25
$5.3M
$697.2M
Q4 24
$7.3M
$757.4M
Q3 24
$76.1M
$784.0M
Q2 24
$6.0M
$809.1M
Q1 24
$5.5M
$780.6M
Total Debt
CUZ
CUZ
RGEN
RGEN
Q4 25
$3.3B
$542.2M
Q3 25
$3.3B
$537.9M
Q2 25
$3.5B
Q1 25
$3.0B
Q4 24
$3.1B
$525.6M
Q3 24
$2.7B
Q2 24
$2.6B
Q1 24
$2.6B
Stockholders' Equity
CUZ
CUZ
RGEN
RGEN
Q4 25
$4.7B
$2.1B
Q3 25
$4.7B
$2.1B
Q2 25
$4.8B
$2.1B
Q1 25
$4.8B
$2.0B
Q4 24
$4.8B
$2.0B
Q3 24
$4.4B
$2.0B
Q2 24
$4.5B
$2.0B
Q1 24
$4.5B
$2.0B
Total Assets
CUZ
CUZ
RGEN
RGEN
Q4 25
$8.9B
$2.9B
Q3 25
$8.9B
$2.9B
Q2 25
$9.1B
$2.9B
Q1 25
$8.7B
$2.9B
Q4 24
$8.8B
$2.8B
Q3 24
$7.8B
$2.8B
Q2 24
$7.7B
$2.9B
Q1 24
$7.7B
$2.8B
Debt / Equity
CUZ
CUZ
RGEN
RGEN
Q4 25
0.71×
0.26×
Q3 25
0.70×
0.26×
Q2 25
0.73×
Q1 25
0.63×
Q4 24
0.64×
0.27×
Q3 24
0.60×
Q2 24
0.58×
Q1 24
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CUZ
CUZ
RGEN
RGEN
Operating Cash FlowLast quarter
$402.3M
$25.7M
Free Cash FlowOCF − Capex
$135.0M
$17.6M
FCF MarginFCF / Revenue
53.0%
8.9%
Capex IntensityCapex / Revenue
104.8%
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CUZ
CUZ
RGEN
RGEN
Q4 25
$402.3M
$25.7M
Q3 25
$120.5M
$48.1M
Q2 25
$122.6M
$28.6M
Q1 25
$44.8M
$15.0M
Q4 24
$400.2M
$39.2M
Q3 24
$117.4M
$49.3M
Q2 24
$125.5M
$42.2M
Q1 24
$28.3M
$44.7M
Free Cash Flow
CUZ
CUZ
RGEN
RGEN
Q4 25
$135.0M
$17.6M
Q3 25
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$147.5M
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
CUZ
CUZ
RGEN
RGEN
Q4 25
53.0%
8.9%
Q3 25
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
65.5%
19.3%
Q3 24
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
CUZ
CUZ
RGEN
RGEN
Q4 25
104.8%
4.1%
Q3 25
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
112.2%
3.2%
Q3 24
4.5%
Q2 24
3.1%
Q1 24
5.5%
Cash Conversion
CUZ
CUZ
RGEN
RGEN
Q4 25
1.93×
Q3 25
14.03×
3.23×
Q2 25
8.46×
1.92×
Q1 25
2.14×
2.57×
Q4 24
29.35×
Q3 24
10.48×
Q2 24
16.01×
12.70×
Q1 24
2.13×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CUZ
CUZ

Rental Properties$253.3M99%
Fee And Other Revenue$1.7M1%
Other$1.2M0%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons